Review
Published on 01 Apr 2021
In Vivo and Ex Vivo Pediatric Brain Tumor Models: An Overview
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.620831
- 14,540 views
- 33 citations
- Frontiers in Oncology
- Pediatric Oncology
- Articles
Type at least 3 characters
667 articles
articles
Original Research
Published on 01 Apr 2021
Identification of Ten Core Hub Genes as Potential Biomarkers and Treatment Target for Hepatoblastoma
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.591507
- 9,154 views
- 17 citations
Original Research
Published on 30 Mar 2021
Management of Oral Mucositis in Children With Malignant Solid Tumors
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.599243
- 9,883 views
- 19 citations
Original Research
Published on 30 Mar 2021
Clinical and Molecular Differentiation Between Malignant Rhabdoid Tumor of the Kidney and Normal Tissue: A Two-Case Report
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.659709
- 3,652 views
- 9 citations
Review
Published on 25 Mar 2021
Dasatinib in the Management of Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.632231
- 14,970 views
- 17 citations
Original Research
Published on 22 Mar 2021
NSG Mice Facilitate ex vivo Characterization of Ewing Sarcoma Lung Metastasis Using the PuMA Model
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.645757
- 4,986 views
- 6 citations
Original Research
Published on 18 Mar 2021
Single-Cell RNA-seq Reveals Characteristics of Malignant Cells and Immune Microenvironment in Subcutaneous Panniculitis-Like T-Cell Lymphoma
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.611580
- 10,163 views
- 12 citations
Original Research
Published on 16 Mar 2021
Serum Protein N-Glycosylation Signatures of Neuroblastoma
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.603417
- 4,944 views
- 11 citations
Original Research
Published on 16 Mar 2021
Inhibition of the mRNA-Binding Protein IGF2BP1 Suppresses Proliferation and Sensitizes Neuroblastoma Cells to Chemotherapeutic Agents
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.608816
- 6,161 views
- 18 citations
Original Research
Published on 09 Mar 2021
Prognostic Signature of Immune Genes and Immune-Related LncRNAs in Neuroblastoma: A Study Based on GEO and TARGET Datasets
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.631546
- 7,089 views
- 18 citations
Mini Review
Published on 09 Mar 2021
Fertility Preservation in Female Pediatric Patients With Cancer: A Clinical and Regulatory Issue
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.641450
- 10,068 views
- 17 citations
Original Research
Published on 08 Mar 2021
Immune Effector Cell Associated Neurotoxicity (ICANS) in Pediatric and Young Adult Patients Following Chimeric Antigen Receptor (CAR) T-Cell Therapy: Can We Optimize Early Diagnosis?
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.634445
- 40,269 views
- 46 citations
Original Research
Published on 08 Mar 2021
Beginning Restorative Activities Very Early: Implementation of an Early Mobility Initiative in a Pediatric Onco-Critical Care Unit
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.645716
- 11,426 views
- 12 citations
Original Research
Published on 26 Feb 2021
A Survival-Related Competitive Endogenous RNA Network of Prognostic lncRNAs, miRNAs, and mRNAs in Wilms Tumor
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.608433
- 4,052 views
- 12 citations
Original Research
Published on 26 Feb 2021
Influence of Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphism on High-Dose Methotrexate-Related Toxicities in Pediatric Non-Hodgkin Lymphoma Patients
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.598226
- 4,356 views
- 11 citations
Review
Published on 26 Feb 2021
Continuous Renal Replacement Therapy: A Review of Use and Application in Pediatric Hematopoietic Stem Cell Transplant Recipients
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.632263
- 6,982 views
- 18 citations
Original Research
Published on 25 Feb 2021
Clinician Emotions Surrounding Pediatric Oncology Patient Deterioration
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.626457
- 8,284 views
- 23 citations
Perspective
Published on 24 Feb 2021
Perspective: A Framework to Screen Pediatric and Adolescent Hematopoietic Cellular Therapy Patients for Organ Dysfunction: Time for a Multi-Disciplinary and Longitudinal Approach
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.622630
- 2,812 views
- 6 citations
Review
Published on 24 Feb 2021
Non-Coding RNAs Participate in the Pathogenesis of Neuroblastoma
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.617362
- 4,536 views
- 9 citations
Original Research
Published on 23 Feb 2021
Defining the Extracellular Matrix of Rhabdomyosarcoma
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.601957
- 7,538 views
- 15 citations
Mini Review
Published on 22 Feb 2021
Rhabdoid Tumor Predisposition Syndrome: From Clinical Suspicion to General Management
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.586288
- 14,183 views
- 45 citations
Original Research
Published on 17 Feb 2021
Treatment-Related Toxicities During Anti-GD2 Immunotherapy in High-Risk Neuroblastoma Patients
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.601076
- 9,706 views
- 37 citations
Original Research
Published on 05 Feb 2021
Re-Emergence of Minimal Residual Disease Detected by Flow Cytometry Predicts an Adverse Outcome in Pediatric Acute Lymphoblastic Leukemia
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.596677
- 4,629 views
- 9 citations
Review
Published on 04 Feb 2021
Case Discussion and Literature Review: Cancer Immunotherapy, Severe Immune-Related Adverse Events, Multi-Inflammatory Syndrome, and Severe Acute Respiratory Syndrome Coronavirus 2
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.625707
- 6,256 views
- 10 citations